Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pluristem Therapeutics Inc (NASDAQ:PSTI)

1.55
Delayed Data
As of Dec 05
 +0.08 / +5.44%
Today’s Change
0.71
Today|||52-Week Range
1.85
+37.17%
Year-to-Date
No recent news for Pluristem Therapeutics Inc.

Today’s Trading

Previous close1.47
Today’s open1.53
Day’s range1.52 - 1.56
Volume148,738
Average volume (3 months)136,136
Market cap$119.1M
Dividend yield--
Data as of 3:59pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)+17.14%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+651.19%
P/E ratioNM
Price/Sales37.16
Price/Book3.09

Competitors

 Today’s
change
Today’s
% change
ADVMAdverum Biotechnolog...+0.15+5.26%
BPTHBio Path Holdings In...+0.06+4.80%
AXSMAxsome Therapeutics ...+0.10+1.63%
--Wang On Group Ltd0.000.00%
Data as of 3:59pm ET, 12/05/2016

Financials

Next reporting dateFebruary 3, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$2.8M
Annual profit (last year)-$23.2M
Net profit margin-816.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Zami Aberman
President, COO, CFO, Secretary &
Director
Yaky Yanay
Corporate headquarters
Haifa, Haifa

Forecasts


Search for Jobs